Surrozen, Inc.
General ticker "SRZN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $34.1M (TTM average)
Surrozen, Inc. follows the US Stock Market performance with the rate: 32.7%.
Estimated limits based on current volatility of 6.0%: low 15.48$, high 17.29$
Factors to consider:
- Total employees count: 42 (-43.2%) as of 2023
- Top business risk factors: Net losses and future profitability, Labor/talent shortage/retention, Operational and conduct risks, Acquisition/divestiture risks, Cybersecurity threats
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [5.78$, 17.97$]
- 2025-12-31 to 2026-12-31 estimated range: [3.58$, 11.78$]
Financial Metrics affecting the SRZN estimates:
- Negative: with PPE of -0.8 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -48.68 <= 0.33
- Positive: Investing cash flow per share per price, % of -0.07 > -0.66
- Negative: Shareholder equity ratio, % of -44.11 <= 18.93
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Inventory ratio change, % of 0 <= 0
Short-term SRZN quotes
Long-term SRZN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $12.50MM | $0.00MM | $10.65MM |
| Operating Expenses | $56.84MM | $45.78MM | $36.19MM |
| Operating Income | $-44.34MM | $-45.78MM | $-25.54MM |
| Non-Operating Income | $8.21MM | $2.98MM | $-38.02MM |
| R&D Expense | $37.01MM | $27.23MM | $21.13MM |
| Income(Loss) | $-36.13MM | $-42.80MM | $-63.56MM |
| Profit(Loss)* | $-36.00MM | $-43.04MM | $-63.56MM |
| Stockholders Equity | $76.00MM | $37.94MM | $-21.38MM |
| Assets | $89.44MM | $46.08MM | $48.47MM |
| Operating Cash Flow | $-44.15MM | $-40.36MM | $-17.63MM |
| Capital expenditure | $0.73MM | $0.40MM | $0.03MM |
| Investing Cash Flow | $38.31MM | $51.72MM | $-0.03MM |
| Financing Cash Flow | $-2.56MM | $0.28MM | $16.18MM |
| Earnings Per Share** | $-15.55 | $-21.33 | $-21.67 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.